JNJ-90301900 clinical trials

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

This study is looking at a new treatment called JNJ-90301900 for a type of lung cancer. It combines this new drug with standard chemotherapy, radiation, and another immunotherapy to see if it helps more people get better.